1. 319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine. (9th November 2020) Authors: Bota, Daniela; Piccioni, David; Duma, Christopher; LaRocca, Renato; Kesari, Santosh; Carrillo, Jose; O'Donnell, Robert; Aiken, Robert; Hsu, Frank; Kong, Xiao-Tang; Taylor, Thomas; Nistor, Gabriel; Dillman, Robert Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine. (9th November 2020) Authors: Bota, Daniela; Piccioni, David; Duma, Christopher; LaRocca, Renato; Kesari, Santosh; Carrillo, Jose; O'Donnell, Robert; Aiken, Robert; Hsu, Frank; Kong, Xiao-Tang; Taylor, Thomas; Nistor, Gabriel; Dillman, Robert Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Beyond the chemotherapy for brain tumor treatment in neuro-oncology practice. Issue 3 (2018) Authors: Kong, Xiao-Tang Journal: Journal of neurology and clinical neuroscience Issue: Volume 2:Issue 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CTIM-09. DOUBLE-BLINDED, PLACEBO CONTROLLED PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA: VACCINE OVERALL SURVIVAL IN BEVACIZUMAB NAIVE AND BEVACIZUMAB RESISTANT PATIENTS. (9th November 2020) Authors: Bota, Daniela; Taylor, Thomas; Kong, Xiao-Tang; Fu, Beverly; Hsu, Frank; Strik, Ankie; Schijns, Virgil; Stathopoulos, Apostolos Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CTIM-26. PATIENT-SPECIFIC DENDRITIC CELL VACCINE (DC-ATA) PULSED WITH ANTIGENS FROM SELF-RENEWING AUTOLOGOUS TUMOR CELLS IN THE TREATMENT OF NEWLY-DIAGNOSED GLIOBLASTOMA: A PHASE II TRIAL. (9th November 2020) Authors: Bota, Daniela; Piccioni, David; LaRocca, R; Duma, Christopher; Kesari, Santosh; Carrillo, Jose; O'Donnell, Robert T; Aiken, Robert; Hsu, Frank; Kong, Xiao-Tang; Hsieh, Candace; Langford, Chris; Carta, Krystal; Wang, Adrienne; Langford, James; Taylor, Thomas; Nistor, Gabriel; Dillman, Robert Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CTIM-33. PHASE II TRIAL OF VACCINE IMMUNOTHERAPY IN PRIMARY GLIOBLASTOMA: ADJUNCTIVE AUTOLOGOUS DENDRITIC CELLS PULSED WITH LYSATE FROM IRRADIATED SELF-RENEWING AUTOLOGOUS TUMOR CELLS (AV-GBM-1). (12th November 2021) Authors: Bota, Daniela A; Piccioni, David E; Duma, Christopher M; LaRocca, Renato V; Kesari, Santosh; Abedi, Mehrdad; Carrillo, Jose A; Aiken, Robert D; Hsu, Frank; Kong, Xiao-Tang; Taylor, Thomas H; Hsieh, Candace; Nistor, Gabriel; Dillman, Robert Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CTNI-23. PRELIMINARY SAFETY AND PHARMACOKINETICS DATA FOR A PHASE 1B TRIAL OF TELAGLENASTAT IN COMBINATION WITH RADIATION THERAPY AND TEMOZOLOMIDE IN PATIENTS WITH IDH-MUTANT GRADE 2/3 ASTROCYTOMA (NCI-10218). (14th November 2022) Authors: Kizilbash, Sani; Piccioni, David; Sahebjam, Solmaz; Villano, John; Jaeckle, Kurt; Welch, Mary; Kong, Xiao-Tang; Holdhoff, Matthias; Lammers, Anita; Remick, Adam; Reid, Joel; Allred, Jacob; Port, John; Lanza, Ian; McBrayer, Samuel; Kunos, Charles; Shapiro, Geoffrey; Adjei, Alex Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. From "One-Size-Fits-All" to a precision medicine approach in neuro-oncology and neurology practice. Issue 1 (2017) Authors: Kong, Xiao-Tang Journal: Journal of neurology and clinical neuroscience Issue: Volume 1:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. IMMU-27. LONG TERM STABILIZATION OF RECURRENT HIGH-GRADE GLIOMA WITH PD-1 INHIBITOR PEMBROLIZUMAB IN TWO CASES. (12th November 2021) Authors: Moldenhauer, Matthew; Du, Steven; Fu, Dan; Myung, Joon; Bota, Daniela; Kong, Xiao-Tang Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. INNV-10. TUMOR TREATING FIELDS (TTF) AS MAINTENANCE THERAPY FOR AN OLIGODENDROGLIOMA CASE AND LONG-TERM FOLLOW-UP. (12th November 2021) Authors: Ko, Uvin; Du, Steven; Moldenhauer, Matthew; Kong, Xiao-Tang Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗